β2-adrenergic receptor autoantibodies alleviated myocardial damage induced by β1-adrenergic receptor autoantibodies in heart failure
Authors:
- 8 May 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 114 (11) , 1487-1498
Abstract
β1-adrenergic receptor autoantibodies (β1-AAs) and β2-adrenergic receptor autoantibodies (β2-AAs) are present in patients with heart failure (HF); however, their interrelationship with cardiac structure and function remains unknown. This study explored the effects of the imbalance between β1-AAs and β2-AAs on cardiac structure and its underlying mechanisms in HF. Patients with left systolic HF who suffered from coronary heart disease (65.9%) or dilated cardiomyopathy (34.1%) were divided into New York Heart Association Classes I–II (n = 51) and Classes III–IV (n = 37) and compared with healthy volunteers as controls (n = 41). Total immunoglobulin G from HF patient serum comprising β1-AAs and/or β2-AAs were determined and purified for in vitro studies from neonatal rat cardiomyocytes (NRCMs). In addition, HF was induced by doxorubicin in mice. We observed that the increased ratio of β1-AAs/β2-AAs was associated with worsening HF in patients. Moreover, β2-AAs from patients with HF suppressed the hyper-shrinking and apoptosis of NRCMS induced by β1-AAs from some patients. Finally, β2-AAs alleviated both myocardial damage and β1-AAs production induced by doxorubicin in mice. β2-AAs were capable of antagonizing the effects imposed by β1-AAs both in vitro and in vivo. The imbalance of β1-AAs and β2-AAs in patients with HF is a mechanism underlying HF progression, and the increasing ratio of β1-AAs/β2-AAs should be considered a clinical assessment factor for the deterioration of cardiac function in patients with HF.Keywords
Funding Information
- Natural Science Foundation of Beijing (7151001)
- National Natural Science Foundation of China (91539205)
- National Science Foundation of China (31401006, 81770393)
This publication has 26 references indexed in Scilit:
- Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalizationCardiovascular Research, 2012
- Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndromePain, 2011
- Targeting Receptor Antibodies in Immune CardiomyopathySeminars in Thrombosis and Hemostasis, 2010
- Dynamic Protein Kinase A Activities Induced by β-Adrenoceptors Dictate Signaling Propagation for Substrate Phosphorylation and Myocyte ContractionCirculation Research, 2009
- Anti-beta1-adrenoreceptor autoantibodies and myocardial sympathetic nerve activity in chronic heart failureInternational Journal of Cardiology, 2008
- What Is the Role of β-Adrenergic Signaling in Heart Failure?Circulation Research, 2003
- Myocyte Adrenoceptor Signaling PathwaysScience, 2003
- Agonistic Anti-β1-Adrenergic Receptor Autoantibodies From Cardiomyopathy Patients Reduce the β1-Adrenergic Receptor Expression in Neonatal Rat CardiomyocytesCirculation, 1998
- Anti-β1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loopsJournal of Molecular and Cellular Cardiology, 1995
- Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect.Circulation, 1994